SC0T:F:F-Invesco Markets plc - Invesco STOXX Europe 600 Optimised Health Care UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 385.35

Change

0.00 (0.00)%

Market Cap

USD 7.20M

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.15 (-0.57%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.26 (-0.51%)

USD 113.22B
SXR8:F iShares Core S&P 500 UCITS ETF..

+1.00 (+0.19%)

USD 83.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.30 (-0.56%)

USD 77.76B
FRCJ:F UBS MSCI Japan Socially Respon..

-0.14 (-0.63%)

USD 73.13B
EUNL:F iShares Core MSCI World UCITS ..

+0.09 (+0.09%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.10 (+0.04%)

USD 56.29B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.08 (-0.51%)

USD 54.81B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.04 (+0.05%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.22 (+0.24%)

USD 51.63B

ETFs Containing SC0T:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.34% 69% C- 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.34% 67% D+ 60% D-
Trailing 12 Months  
Capital Gain 2.75% 39% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.75% 37% F 48% F
Trailing 5 Years  
Capital Gain 51.65% 75% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 51.65% 75% C 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 7.58% 75% C 71% C-
Dividend Return 7.58% 74% C 65% D
Total Return N/A 62% D 47% F
Risk Return Profile  
Volatility (Standard Deviation) 8.71% 64% D 84% B
Risk Adjusted Return 86.96% 96% N/A 95% A
Market Capitalization 7.20M 3% F 9% A-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.